Cardiac antigen recognized as mechanism for coronary heart complication with immunotherapy-related myocarditis

Myocarditis is a complication that may happen in most cancers sufferers handled with immune checkpoint inhibitors. Though the adversarial occasion is uncommon — affecting lower than 1% of sufferers given the immunotherapy — the mortality charge is almost 50%. Now, researchers have recognized the mechanism for the lethal coronary heart irritation.